Volume 3 Number 6
June 2015

Home > Publications > Prostate Oncology > Volume 3 - Year 2015 > Number 6, June 2015

Contents


Detection, diagnosis and evaluation

Lorente D, Mateo J, de Bono JS.
Molecular characterization and clinical utility of circulating tumor cells in the treatment of prostate cancer.
Am Soc Clin Oncol Educ Book. 2014:e197-203. doi: 10.14694/EdBook_AM.2014.34.e197.
Abstract | Full text | Similar articles

Biomarkers
Cary KC, Cooperberg MR.
Biomarkers in prostate cancer surveillance and screening: past, present, and future.
Ther Adv Urol. 2013 Dec;5(6):318-29. doi: 10.1177/1756287213495915.
Abstract | Full text | Similar articles

Virginie VG.
Prognostic accuracy of prostate health index and urinary prostate cancer antigen 3 in predicting pathologic features after radical prostatectomy.
Urol Oncol. 2015 Jan 6. pii: S1078-1439(15)00271-9. doi: 10.1016/j.urolonc.2015.05.027. [Epub ahead of print]
Abstract | Similar articles

Grading
Carter HB, Partin AW, Walsh PC, Trock BJ, Veltri RW, Nelson WG, Coffey DS, Singer EA, Epstein JI.
Gleason score 6 adenocarcinoma: should it be labeled as cancer?
J Clin Oncol. 2012 Dec 10;30(35):4294-6. doi: 10.1200/JCO.2012.44.0586. Epub 2012 Oct 1.
Abstract | Full text | Similar articles

Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL; ISUP Grading Committee.
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
Am J Surg Pathol. 2005 Sep;29(9):1228-42.
Abstract | Full text | Similar articles

Freeman A.
Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.
BJU Int. 2013 May;111(5):691-2. doi: 10.1111/j.1464-410X.2012.11743.x.
Abstract | Full text | Similar articles

Loeb S, Montorsi F, Catto JW.
Future-proofing Gleason Grading: What to Call Gleason 6 Prostate Cancer?
Eur Urol. 2015 Jul;68(1):1-2. doi: 10.1016/j.eururo.2015.02.038. Epub 2015 Mar 11.
Abstract | Full text | Similar articles

Prognosis and outcome

Keane FK, Chen MH, Zhang D, Moran BJ, Braccioforte MH, D'Amico AV.
Androgen deprivation therapy and the risk of death from prostate cancer among men with favorable or unfavorable intermediate-risk disease.
Cancer. 2015 Apr 29. doi: 10.1002/cncr.29420. [Epub ahead of print]
Abstract | Similar articles

Lin CC, Gray PJ, Jemal A, Efstathiou JA.
Androgen deprivation with or without radiation therapy for clinically node-positive prostate cancer.
J Natl Cancer Inst. 2015 May 9;107(7). pii: djv119. doi: 10.1093/jnci/djv119. Print 2015 Jul.
Abstract | Similar articles

McPhail S, Johnson S, Greenberg D, Peake M, Rous B.
Stage at diagnosis and early mortality from cancer in England.
Br J Cancer. 2015 Mar 31;112 Suppl 1:S108-15. doi: 10.1038/bjc.2015.49.
Abstract | Full text | Similar articles

Natural history of localised prostatic cancer
Popiolek M, Rider JR, Andrén O, Andersson SO, Holmberg L, Adami HO, Johansson JE.
Natural history of early, localized prostate cancer: a final report from three decades of follow-up.
Eur Urol. 2013 Mar;63(3):428-35. doi: 10.1016/j.eururo.2012.10.002. Epub 2012 Oct 13.
Abstract | Full text | Comments | Similar articles

Studer UE.
A historical landmark study comes to its end.
Eur Urol. 2013 Mar;63(3):436-7. doi: 10.1016/j.eururo.2012.10.050. Epub 2012 Nov 5.
Abstract | Full text | Similar articles

Johansson JE, Andrén O, Andersson SO, Dickman PW, Holmberg L, Magnuson A, Adami HO.
Natural history of early, localized prostate cancer.
JAMA. 2004 Jun 9;291(22):2713-9.
Abstract | Full text | Similar articles

Johansson JE, Holmberg L, Johansson S, Bergström R, Adami HO.
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden.
JAMA. 1997 Feb 12;277(6):467-71. Erratum in: JAMA 1997 Jul 16;278(3):206.
Abstract | Similar articles

Johansson JE, Adami HO, Andersson SO, Bergström R, Holmberg L, Krusemo UB.
High 10-year survival rate in patients with early, untreated prostatic cancer.
JAMA. 1992 Apr 22-29;267(16):2191-6.
Abstract | Similar articles

Johansson JE, Adami HO, Andersson SO, Bergström R, Krusemo UB, Kraaz W.
Natural history of localised prostatic cancer. A population-based study in 223 untreated patients.
Lancet. 1989 Apr 15;1(8642):799-803.
Abstract | Similar articles

 

This website is certified by Health On the Net Foundation. Click to verify. www.prostate-cancer-today.org
Home Prostate OncologyRecurrent Prostate Cancer
LibraryPublications
About UsE-mail Alert ServiceJournals Privacy Policy